Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
1.35
+0.03 (2.27%)
At close:
May 31, 2023, 4:00 PM
1.40
+0.05 (3.70%)
After-hours:
May 31, 2023, 5:46 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.91 | 11.25 | 8.88 | 13.92 | 11.33 | 7.35 | 14.22 | 8.66 | 5.33 | 3.3 | |
| Revenue Growth (YoY) | 14.81% | 26.62% | -36.18% | 22.81% | 54.11% | -48.29% | 64.20% | 62.59% | 61.33% | 22.03% | |
| Cost of Revenue | 6.7 | 4.5 | 3.81 | 7.15 | 7.02 | 5.28 | 11.27 | 7.48 | 3.77 | 2.72 | |
| Gross Profit | 6.21 | 6.75 | 5.07 | 6.76 | 4.31 | 2.07 | 2.95 | 1.18 | 1.56 | 0.59 | |
| Selling, General & Admin | 18.14 | 18.03 | 15.45 | 18.81 | 25.49 | 23.87 | 21.85 | 16.26 | 14.49 | 8.2 | |
| Research & Development | 3.63 | 2.55 | 2.47 | 4.6 | 5.85 | 9.48 | 8.88 | 6.48 | 3.87 | 2.68 | |
| Other Operating Expenses | 0 | 0 | 0.43 | 0 | 0 | 0.66 | 0 | 0 | 0 | 0 | |
| Operating Expenses | 21.77 | 20.58 | 18.36 | 23.4 | 31.34 | 34.01 | 30.73 | 22.74 | 18.35 | 10.88 | |
| Operating Income | -15.56 | -13.83 | -13.29 | -16.64 | -27.03 | -31.94 | -27.78 | -21.56 | -16.79 | -10.29 | |
| Interest Expense / Income | 0.16 | 0.11 | 0.14 | 0.38 | 0.6 | 0.65 | 0.02 | 0.01 | 0.44 | 1.73 | |
| Other Expense / Income | -0.63 | -4.18 | 2.4 | -4.89 | -0.64 | -3.47 | -4.33 | -1.98 | 16.54 | -0.13 | |
| Pretax Income | -15.08 | -9.76 | -15.83 | -12.13 | -26.99 | -29.12 | -23.47 | -19.59 | -33.77 | -11.89 | |
| Net Income | -15.08 | -9.76 | -15.83 | -12.13 | -26.99 | -29.12 | -23.47 | -19.59 | -33.77 | -11.89 | |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 10.35 | 4.66 | 0 | 0 | |
| Net Income Common | -15.08 | -9.76 | -15.83 | -12.13 | -26.99 | -29.12 | -33.82 | -24.25 | -33.77 | -11.89 | |
| Shares Outstanding (Basic) | 13 | 12 | 7 | 5 | 4 | 2 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 13 | 12 | 7 | 5 | 4 | 2 | 1 | 1 | 1 | 0 | |
| Shares Change | 5.65% | 71.26% | 49.44% | 17.44% | 71.95% | 91.22% | 27.47% | 30.66% | 273.11% | 4.01% | |
| EPS (Basic) | -1.16 | -0.80 | -2.21 | -2.53 | -6.60 | -12.30 | -28.05 | -24.90 | -45.30 | -59.85 | |
| EPS (Diluted) | -1.16 | -0.88 | -2.21 | -2.53 | -6.60 | -12.30 | -30.75 | -27.45 | -45.30 | -59.85 | |
| Free Cash Flow Per Share | -1.15 | -0.92 | -1.22 | -3.30 | -5.46 | -13.35 | -21.59 | -20.29 | -22.13 | -47.26 | |
| Gross Margin | 48.13% | 60.01% | 57.08% | 48.60% | 38.03% | 28.14% | 20.72% | 13.61% | 29.27% | 17.78% | |
| Operating Margin | -120.48% | -122.96% | -149.64% | -119.56% | -238.53% | -434.43% | -195.36% | -248.94% | -315.26% | -311.75% | |
| Profit Margin | -116.79% | -86.82% | -178.17% | -87.17% | -238.19% | -396.06% | -237.78% | -279.93% | -633.92% | -359.99% | |
| Free Cash Flow Margin | -115.11% | -99.72% | -98.57% | -113.76% | -196.75% | -430.87% | -183.48% | -228.16% | -309.63% | -285.95% | |
| EBITDA | -14.04 | -8.63 | -15.07 | -11.06 | -24.88 | -26.73 | -21.6 | -18.64 | -32.59 | -9.69 | |
| EBITDA Margin | -108.71% | -76.72% | -169.62% | -79.46% | -219.53% | -363.47% | -151.88% | -215.26% | -611.77% | -293.52% | |
| Depreciation & Amortization | 0.89 | 1.02 | 0.62 | 0.69 | 1.52 | 1.75 | 1.86 | 0.93 | 0.75 | 0.47 | |
| EBIT | -14.92 | -9.65 | -15.69 | -11.75 | -26.39 | -28.47 | -23.45 | -19.58 | -33.33 | -10.16 | |
| EBIT Margin | -115.58% | -85.82% | -176.60% | -84.41% | -232.90% | -387.24% | -164.93% | -226.04% | -625.76% | -307.72% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).